11:00 a.m. - 11:10 a.m.
|
Opening Address by Akio Hirohashi
Member of Board, Chief Strategy Officer, Evident Corporation
Chairperson
Dr. Graham Wright
Director, Research Support Centre (RSC)
A*STAR, Singapore
|
|---|
11:10 a.m. - 11:55 a.m.
|
Session 1
JeWells: A New Dedicated Organoids Platform Made for HCS and More Extreme Conditions
Presenter:
Dr. Anne Beghin
Research Assistant Professor
National University of Singapore
More information
|
|---|
11:55 a.m. - 12:40 p.m.
|
Session 2
3D Spheroid-Microvasculature-on-a-Chip for Tumor-Endothelium Mechanobiology Interplay
Presenter:
Dr. Arnold Ju
School of Biomedical Engineering,
Faculty of Engineering and Sydney Nano Institute
The University of Sydney, Australia
More information
|
|---|
12:40 p.m. – 1:25 p.m.
|
Session 3
A Sugar Code for the Dynamics of Breast Cancer Migration
Presenter:
Dr. Ramray Bhat
Assistant Professor
Indian Institute of Science, Bangalore, India
More information
|
|---|
1:25 p.m. – 2:10 p.m.
|
Session 4
Complex In Vitro Tumor Models and 3D Confocal Imaging Technology to Investigate Cell Therapy against Solid Tumor
Presenter:
Dr. Fuqian Xie
Cofounder and Chief Scientific Officer
Shanghai Biocast Biotechnology Co. Ltd., Shanghai, China
More information
|
|---|
2:10 p.m. – 2:55 p.m.
|
Session 5
Genotype-Phenotype Association Strategy for Fatty Liver Diseases Using Human iPSC-Derived Organoids
Presenter:
Dr. Yosuke Yoneyama
Assistant Professor
Tokyo Medical and Dental University, Japan
More information
|
|---|
2:55 p.m. – 3:00 p.m.
|
Closing Address by Jian Shen
General Manager, Life Science
Evident APAC
|
|---|
모바일